Beth Hecht Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Beth Hecht.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Beth Hecht. Beth Hecht is See Remarks in XERIS PHARMACEUTICALS INC ($XERS) and Director in AYTU BIOPHARMA, INC ($AYTU) and Director in Neos Therapeutics, Inc. ($NEOS).
Latest Insider Trading Transactions of Beth Hecht
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AYTU, NEOS, XERS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12 2021 | AYTU | AYTU BIOPHARMA, IN ... | Hecht Beth | Director | Grant | A | 0.00 | 6,500 | 0 | 9,052 | 2.6 K to 9.1 K (+254.70 %) |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | D | 1.44 | 46,907 | 67,546 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | D | 6.05 | 22,756 | 137,674 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | D | 7.65 | 18,322 | 140,163 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | D | 9.63 | 14,777 | 142,303 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | D | 19.82 | 12,500 | 247,750 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Sell | D | 0.00 | 23,453 | 0 | 0 | 23.5 K to 0 (-100.00 %) |
| Feb 01 2021 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Grant | A | 0.00 | 150,000 | 0 | 210,814 | 60.8 K to 210.8 K (+246.65 %) |
| Jul 15 2020 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Grant | A | 2.26 | 3,731 | 8,432 | 60,814 | 57.1 K to 60.8 K (+6.54 %) |
| Jun 11 2020 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Grant | A | 0.00 | 23,453 | 0 | 23,453 | 0 to 23.5 K |
| Mar 16 2020 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Buy | P | 1.97 | 4,000 | 7,880 | 57,083 | 53.1 K to 57.1 K (+7.54 %) |
| Mar 02 2020 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Grant | A | 0.00 | 45,000 | 0 | 53,083 | 8.1 K to 53.1 K (+556.72 %) |
| Mar 02 2020 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Grant | A | 0.00 | 45,000 | 0 | 53,083 | 8.1 K to 53.1 K (+556.72 %) |
| Feb 18 2020 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Buy | P | 4.15 | 4,000 | 16,600 | 8,083 | 4.1 K to 8.1 K (+97.97 %) |
| Jan 06 2020 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Grant | A | 5.99 | 459 | 2,749 | 4,083 | 3.6 K to 4.1 K (+12.67 %) |
| Jul 03 2019 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Grant | A | 9.72 | 1,124 | 10,925 | 3,928 | 2.8 K to 3.9 K (+40.09 %) |
| Jun 17 2019 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | A | 1.44 | 46,907 | 67,546 | 46,907 | |
| Feb 22 2019 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Buy | P | 10.00 | 2,500 | 25,000 | 2,500 | 0 to 2.5 K |
| Feb 01 2019 | XERS | XERIS PHARMACEUTIC ... | Hecht Beth | See Remarks | Option Exercise | A | 13.88 | 32,500 | 451,100 | 32,500 | |
| Jul 05 2016 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | A | 9.63 | 14,777 | 142,303 | 14,777 | |
| Oct 01 2015 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | P | 19.82 | 12,500 | 247,750 | 12,500 |
Page: 1